ARTICLE INFO

Article Type

Original Research

Authors

Nakhzari Khodakheir   j. (*)
Haghighi   A.H. (1)
Hamedinia   M.R. (1)
Ahmadi   A. (1)






(*) Department of Sport Science, Faculty of Literature, Zabol University, Zabol, Iran
(1) Department of Sport Physiology, Faculty of Sport Sciences, Hakim Sabzevari University, Sabzevar, Iran

Correspondence

Address: Department of Sport Science, Faculty of Literature, Zabol University, Zabol, Iran
Phone: +98 915-939-5542
Fax: +98 54-322-35478
javadnakhzari@uoz.ac.ir

Article History

Received:  February  6, 2018
Accepted:  June 26, 2018
ePublished:  October 10, 2018

BRIEF TEXT


Multiple sclerosis (MS) is an autoimmune, inflammatory, chronic, and progressive disease, in which the immune system attacks neurons in the brain and spinal cord and causes damage to the myelin sheath and the exon of these cells [1].

... [2-16]. Regular endurance exercise leads to improved intestinal and bladder function, decreased fatigue and depression, increased intake of oxygen and positive attitudes in MS patients [17-19]. Also, progressive resistance training is considered as a very useful sport-based intervention for patients [14]. Coenzyme Q10 or ubiquinone is a vitamin-like compounds and fat-soluble, which can be found in eukaryotic cells, especially in mitochondria. This coenzyme is a part of the electron transport chain and energy production in the aerobic metabolism pathway [20-22]. 200-500 mg/day daily intake of coenzyme Q10 can be beneficial for MS patients [23-26]. ... [27].

The purpose of this research was to investigate the effect of 8 weeks of combined exercise training (more aerobic and resistance) and supplementation of coenzyme Q10 on muscle function (sitting, rising and walking speed) in patients with MS.

The present study is a semi-experimental (single-blinded) research with pre-test and post-test design.

The present study was done on men and women aged 25-45 years old (mean age: 37.60±7.14, weight: 64.57±9.42 and BMI: 24.30±1.66) who were the members of MS Association of Mahhad with the disability scale of 3-5 in 2016.

In this study, 28 male and female members of the MS Association of Mashhad were selected using convenience sampling method.

The present study was semi-experimental (single-blinded) research with pre-test-posttest design with three experimental groups (combined exercise+Q10 supplement, combined exercise+placebo and Q10 supplement) and a control (placebo). According to the inclusion criteria (a history of MS for at least 2 years, no regular exercise, no smoking and no consumption of immunosuppressive drugs), the volunteers were enrolled in the study. Exclusion criteria included MS recurrence, musculoskeletal injuries, inability to exercise, and no regular participation in the exercise protocol. All subjects completed the consent of collaboration in the research. The research method was confirmed and registered by the Ethics Committee of Sabzevar University of Medical Sciences (ethics code IR.MEDSAB.REC.1395.20). The combined exercise+ Q10 supplement and exercise+placebo experienced a combined exercise program (two sessions of endurance training and one session of resistance training per week) for eight 3-session weeks weekly. The aerobic exercise included a 3-min jogging on bike ergometer with 1-2 min intervals between each set. It increased from 5 replicates in the first session to 12 repetitions in the final session. To observe overload, the intensity began with 50% of maximum heart rate and at the end of the course reached to 60%. Strength training included bench press, lat, leg extension, and hamstring exercises. The exercises were carried out in three sets with 10 to 8 replications and a 2-4-min interval between each set and also a 3-4-min interval between each move according to the overload. Each session of the exercise included warming up (5-10 min), the main training with variable length and cool down exercises (5-10 min). Coenzyme Q10 (Nutri Century; Canada) was used as a supplement to the experimental exercise group as well as the third experimental group as capsule (200 mg) daily supervise by a neurologist and also starch was also used as a placebo [28]. Functional tests included chair stand, up & go [29], 25-foot walk and 6-min walk [30] tests were measured to evaluate muscle performance before and after the exercise protocol. The chair stand test assesses muscle strength, which its time is measured 5 or 10 times or the number of tests performed in 30 s is considered. Up & go test measures the time it takes the patient to rise from a standard chair, walk to a line on the floor 3 meters away, turn, return, and sit down again. This test evaluates movement, balance and agility skills. 25-foot walk test measures the time it takes to walk 25-foot distance, in which the subject is asked to walk straight for 7.5 meters without assistance and in the least possible time. 6-min walk test measures the total covered distance in 6 min, in which is subjected to walk with the maximum speed without rest and encouragement. This test evaluates endurance and ability to walk for long distances. In general, these tests mostly measure balance, coordination, and muscular endurance of the lower limbs in patients. Each test was performed twice and the best (at least) time to carry out the tests was recorded for each individual. Data was analyzed using analysis of covariance and paired t-test.

After eight weeks, the average chair stands increased from 10.28 to 15.71 (Table 1). LSD Post-hoc test showed that the supplement+exercise and exercise groups had a significant difference compared with the supplement group as well as the placebo group, whereas there was no significant difference between the supplement group and the placebo group. The mean time 25-foot walk test test decreased from 7.36 to 6.22 s (Table 2). Post-hoc test showed that there was a significant difference between the supplement+exercise and exercise groups in comparison with the supplement and placebo groups and the supplement group did not show any significant difference compared with the placebo group. The average time of up & go tests also reached from 7.94 to 6.63 s (Table 3). ) Post-hoc test showed that there was a significant difference between the supplement+exercise and exercise groups in comparison with the supplement and placebo groups and the supplement group did not show any significant difference compared with the placebo group. Moreover, the 6-min walk distance reached from 270.50 to 283.25 m (Table 4). Based on the results of post-hoc test, there was a significant difference between the supplement+exercise and exercise groups compared with the supplement and placebo groups, and the supplement group did not significantly differ from the placebo group.

The results of this study indicated that eight weeks of combined exercise with and without supplementation of coenzyme Q10 resulted in a significant reduction in the duration of functional tests, including chair stands, chair stands and walking, 25-foot walking (walking speed). On the other hand, it increased 6-min walk distance (endurance) in supplement and exercise groups compared with supplement and placebo groups, which resulted in improved sitting, rising, walking and ability to change direction. In this regard, Romberg et al. [31] reported that combined training (three sessions per week for six months) resulted in improved walking speed for MS patients. Also, according to another study, the researcher stated that the combined exercise led to improved functional capacity in the training group compared with the control group [32]. ... [33-39].

It is suggested to study the effect of combined exercises with different periods of time and using other dietary supplements.

None declared.

The combined exercise and supplementation with Q10, and even alone, also improves muscle function, including sitting, rising and walking in patients with MS.

The authors are thankful to all the officials and staff of the MS Association of Khorasan Razavi in particular the patients who have contributed to this study for their cooperation.

None declared.

None declared.

This research was extracted from the Ph.D. thesis in Physical Education and Sport Sciences, supported by Hakim Sabzevari University.

TABLES and CHARTS

Show attach file


CITIATION LINKS

[1]Bansi J, Bloch W, Gamper U, Kesselring J. Training in MS: Influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial. Mult Scler. 2013;19(5):613-62.
[2]Kjølhede T, Vissing K, Dalgas U. Multiple sclerosis and progressive resistance training: A systematic review. Mult Scler. 2012;18(9):1215-28.
[3]White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sport Med. 2004;34(15):1077-100.
[4]Harris VK, Sadiq SA. Disease Biomarkers in Multiple Sclerosis. Mol Diagn Ther. 2009;13(4):225-44.
[5]Ransohoff RM, Hafler DA, Lucchinetti CF. Multiple sclerosis-a quiet revolution. Nat Rev Neurol. 2015;11(33):134-42.
[6]Iran MS Society. The history of the establishment of the MS Association of Iran [Internet]. Tehran: Iran MS Society; 2017 [cited 2017 Dec 01]. Available from: http://www.iranms.ir/fa/page/10/
[7]Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol. 2007;61(4):288-99.
[8]Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious Factors. Ann Neurol. 2007;61(6):504-13.
[9]Motl RW. Lifestyle physical activity in persons with multiple sclerosis: The new kid on the MS block. Mult. Scler. 2014;20(8):1025-9.
[10]Van Emmerik RE, Remelius JG, Johnson MB, Chung LH, Kent-Braun JA. Postural control in women with multiple sclerosis: Effects of task, vision and symptomatic fatigue. Gait Posture. 2010;32(4):608-14.
[11]Wetzel JL, Fry DK, Pfalzer LA. Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: Performance and explanatory factors. Physiother Can. 2011;63(2):166-80.
[12]Bowser B, O'Rourke S, Brown CN, White L, Simpson KJ. Sit-to-stand biomechanics of individuals with multiple sclerosis. Clin Biomech (Bristol, Avon). 2015;30(8):788-94.
[13]Pearson M, Dieberg G, Smart N. Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: A meta-analysis. Arch Phys Med Rehabil. 2015;96(7):1339-1348.e7.
[14]Dalgas U, Stenager E. Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis. Mult Scler. 2014;20(2):141-2.
[15]Tallner A, Waschbisch A, Wenny I, Schwab S, Hentschke C, Pfeifer K, et al. Multiple sclerosis relapses are not associated with exercise. Mult Scler. 2012;18(2):232-5.
[16]Courtney AM, Castro-Borrero W, Frohman TC, Frohman EM. Functional treatments in multiple sclerosis. Curr Opin Neurol. 2011;24(3):250-4.
[17]Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol. 1996;39(4):432-41.
[18]Mostert S, Kesselring J. Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler. 2012;8(2):161-8.
[19]Newman MA, Dawes H, van den Berg M, Wade DT, Burridge J, Izadi H. Can aerobic treadmill training reduce the effort of walking and fatigue in people with multiple sclerosis: A pilot study. Mult Scler. 2007;13(1):113-9.
[20]Mancuso M, Orsucci D, Volpi L, Calsolaro V, Siciliano G. Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Current Drug Targets. 2010;11(1):111-21.
[21]Potgieter M, Pretorius E, Pepper MS. Primary and secondary coenzyme Q10 deficiency: The role of therapeutic supplementation. Nutr Rev. 2013;71(3):180-8.
[22]Mohammadi-bardbori A, Hosseini MJ. Therapeutic implication of coenzyme Q10 during statin therapy: Pros and cons. Trends Pharma Sci. 2015;1(3):119-28.
[23]Sanoobar M, Eghtesadi S, Azimi A, Khalili M, Jazayeri S, Reza Gohari M. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis. Int J Neurosci. 2013;123(11):776-82.
[24]Hathcock JN, Shao A. Risk assessment for coenzyme Q10 (Ubiquinone). Regul Toxicol Pharmacol. 2006;45(3):282-8.
[25]Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial. Nutr Neurosci. 2016;19(3):138-43.
[26]Parsa N, Hosseini ZS. New Scientific Findings on Multiple Sclerosis Disease. Sci Cultiv. 2012;2(2):20-8. [Persian]
[27]Bernardi M, Rosponi A, Castellano V, Rodio A, Traballesi M, Delussu AS, et al. Determinants of sit-to-stand capability in the motor impaired elderly. J Electromyogr Kinesiol. 2004;14(3):401-10.
[28]Haghighi A, Heshmati Kia A, Hosseini Kakhak A. The effect of caffeine and ephedrine supplement and their combination on maximal stregnth and muscular endurance in male bodybuilders. J Sport Biosci. 2013;5(4):89-107. [Persian]
[29]Bennell K, Dobson F, Hinman R. Measures of physical performance assessments: Self-Paced Walk Test (SPWT), Stair Climb Test (SCT), Six-Minute Walk Test (6MWT), Chair Stand Test (CST), Timed Up & Go (TUG), Sock Test, Lift and Carry Test (LCT), and Car Task. Arthritis Care Res (Hoboken). 2011;63 Suppl 11:S350-70.
[30]Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler. 2012;18(7):914-24.
[31]Romberg A, Virtanen A, Ruutiainen J, Aunola S, Karppi SL, Vaara M, et al. Effects of a 6-month exercise program on patients with multiple sclerosis: A randomized study. Neurology. 2004;63(11):2034-8.
[32]Romberg A, Virtanen A, Ruutiainen J. Long-term exercise improves functional impairment but not quality of life in multiple sclerosis. J Neurol. 2005;252(7):839-45.
[33]Dettmers C, Sulzmann M, Ruchay-Plössl A, Gütler R, Vieten M. Endurance exercise improves walking distance in MS patients with fatigue. Acta Neurol Scand. 2009;120(4):251-7.
[34]Sabapathy NM, Minahan CL, Turner GT, Broadley SA. Comparing endurance- and resistance-exercise training in people with multiple sclerosis: A randomized pilot study. Clin Rehabil. 2011;25(1):14-24.
[35]Collett J, Dawes H, Meaney A, Sackley C, Barker K, Wade D, et al. Exercise for multiple sclerosis: A single-blind randomized trialcomparing three exercise intensities. Mult Scler. 2011;17(5):594-603.
[36]Cakt BD, Nacir B, Genç H, Saraçoğlu M, Karagöz A, Erdem HR, et al. Cycling Cycling progressive resistance training for people with multiple sclerosis: A randomized controlled study. Am J Phys Med Rehabil. 2010;89(6):446-57.
[37]Kjølhede T, Vissing K, de Place L, Pedersen BG, Ringgaard S, Stenager E, et al. Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up. Mult Scler. 2015;21(5):599-611.
[38]Learmonth YC, Paul L, Miller L, Mattison P, McFadyen AK. The effects of a 12-week leisure centre-based, group exercise intervention for people moderately affected with multiple sclerosis: A randomized controlled pilot study. Clin Rehabil. 2012;26(7):579-93.
[39]Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, et al. Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology. 2009;73(18):1478-84.